-
Company Insights
NewGetinge AB Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our Getinge AB Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. Getinge AB (Getinge) is a medical technology company. It designs, develops, and markets equipment and instruments in the areas related to surgery, infection control, intensive care, care ergonomics, and wound care. The company manufactures an array of medical products such as surgical tables, lights, ventilators, anesthesia equipment, heart-lung machines, patient lifting devices, hospital beds, disinfectors, and documentation systems, among others....
-
Company Insights
NewGradientech AB Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our Gradientech AB Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. Gradientech AB is a biotech and diagnostics company that focuses on ultra-rapid antibiotic susceptibility testing. The company develops next-generation diagnostic tools designed to provide timely medication dosage information. It is headquartered in Uppsala City, Sweden. GlobalData's Medical Devices company profile report, “Gradientech AB Pipeline Insight and Competitive Landscape, 2024" provides information about the company overview and analysis on their pipeline...
-
Product Insights
NewElypta AB Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Elypta AB Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Elypta AB (Elypta) is a molecular diagnostic company that offers cancer preventing and identifying biomakers. The company is developing liquid biopsy platform for earlier detection and closer monitoring biomarkers to generate a score against cancer-type specific signatures. It provides various techniques using artificial intelligence algorithms to prevent cancer mortality. Elypta also offers various investigations ranges from diagnosis to surveillance. The...
-
Product Insights
NewCamurus AB Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Camurus AB Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Camurus AB (Camurus), a subsidiary of Sandberg Development AB, is a pharmaceutical company. It carries out development and commercialization of treatments for the patients suffering from chronic diseases. The company’s major products include CAM2038 to treat chronic pain; CAM2029 to treat acromegaly, GEP-NET and PLD; CAM4072 to treat genetic obesity disorders; CAM2032 to treat Prostate cancer; CAM2043 to treat pulmonary...
-
Product Insights
NewAegirBio AB Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our AegirBio AB Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. AegirBio AB (AegirBio) is a diagnostic company that develops therapeutic drugs in the areas of autoimmune, oncology and neurology space. It offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. The company's products include Veritope, Monator - drug monitoring of tysabri in MS, and Magniareader. It also involves in market innovative diagnostic technologies,...
-
Product Insights
NewAlgoDx AB Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our AlgoDx AB Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. AlgoDx AB (AlgoDx) improves patient outcomes using machine learning technology. The company develops precision medicine using evidence-based algorithm diagnostics and artificial intelligence solutions. AlgoDx is headquartered in Stockholm, Sweden. GlobalData's Medical Devices company profile report, “AlgoDx AB Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their pipeline products. This company profile report provides...
-
Product Insights
New2cureX AB Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our 2cureX AB Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. 2cureX AB is a Sweden-based company engaged in the biotechnology sector. The Company focuses on the research and development of diagnostic substances to select treatment for cancer patients. It is headquartered in Landskrona, Sweden. GlobalData's Medical Devices company profile report, “2cureX AB Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their pipeline products....
-
Product Insights
NewAffibody AB Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Affibody AB Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Affibody AB (Affibody) is a biotech company that discovers and develops next generation biopharmaceuticals and related drugs. It discovers and develops drugs based on its proprietary technology platforms such as Albumod and Affibody molecules. Its Affibody molecules are a class of antibody mimetics that surpass monoclonal antibodies and antibody fragments. Affibody’s Albumod technology is designed to enhance the efficacy of...
-
Product Insights
NewNet Present Value Model: Medivir AB’s Fostroxacitabine Bralpamide Hydrochloride
Empower your strategies with our Net Present Value Model: Medivir AB's Fostroxacitabine Bralpamide Hydrochloride report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: Swedish Orphan Biovitrum AB’s Zurase
Empower your strategies with our Net Present Value Model: Swedish Orphan Biovitrum AB's Zurase report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.